WellDoc

Welldoc, Astellas strike commercialization, development deal bring to BlueStar to East Asia
By Dave Muoio | 03:12 pm | November 21, 2019
Astellas will be paying Welldoc $15 million up front for certain rights to the diabetes digital therapeutic, and will also be on the hook for milestones and royalty payments.
WellDoc's BlueStar cleared for Type 1 diabetes management, CGM integrations
By Dave Muoio | 12:00 pm | November 05, 2019
This is the seventh FDA clearance for the longstanding mobile diabetes management platform.
WellDoc integrates Validic's device ecosystem, More Health's hospital partners and more digital health deals
By Dave Muoio | 11:33 am | May 03, 2019
Also: Microsoft and Imprivata developing healthcare access management platform; SyncThink pairs with QuesGen Systems.
Digital therapeutics startups band together to form new industry group
By Jonah Comstock | 01:21 pm | October 25, 2017
WellDoc founders' new company, Amalgam Rx, gets FDA nod for insulin titration app
By Jonah Comstock | 10:20 am | May 01, 2017
WellDoc's BlueStar secures first mobile health reimbursement
By Brian Dolan | 05:18 am | June 13, 2013
FDA clears WellDoc for diabetes management
By Brian Dolan | 04:15 am | August 02, 2010